Moreover, Beverly Hills Eye Associates offers a variety of premium intraocular lens implants, such as Crystalens®, Trulign, Tecnis Symfony®, and toric ReStor, providing multiple options for improved vision post cataract surgery. The company's comprehensive approach to eye care and its focus on utilizing cutting-edge technologies make it an attractive investment prospect for venture capital firms seeking opportunities in the thriving health care sector. Although specific investment details are currently unavailable, the company's established reputation and commitment to innovation position it as a compelling potential investment for venture capitalists looking to support advancements in eye care. With its long-standing presence in the industry and dedication to utilizing leading-edge technologies, Beverly Hills Eye Associates presents an appealing investment opportunity within the health care sector.
General Information
Get notified when Beverly Hills Eye Associates moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Beverly Hills Eye Associates
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
About Beverly Hills Eye Associates
No funding data available for Beverly Hills Eye Associates yet.
Get notified when Beverly Hills Eye Associates raises fundingBeverly Hills Eye Associates Alternatives & Competitors
A premier LASIK, Cataract, Cornea and General ophthalmology practice in North Texas.
Advanced technology with a loving touch.
Dr. Myles Zakheim has been in private optometric practice in the Los Angeles area since 1980, when h...
FAQ About Beverly Hills Eye Associates
Don't just browse. Track.
Signal Tracker monitors Beverly Hills Eye Associates and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.